This inventor holds 1 USPTO granted patent. Top assignee: University of Michigan. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Fang Cao - Innovator in Cancer Treatment
Introduction
Fang Cao is a notable inventor based in Ann Arbor, MI (US). He has made significant contributions to the field of cancer research through his innovative work in developing small molecule inhibitors.
Latest Patents
Fang Cao holds a patent for "Cyclized peptidomimetic small molecule inhibitors of the WDR5 and MLL1 interaction." This patent discloses cyclic peptidomimetics that inhibit the interaction between MLL1 and WDR5. Additionally, it outlines methods for inhibiting MLL1 activity and treating various cancers.
Career Highlights
Cao is affiliated with the University of Michigan, where he continues to advance his research and contribute to the scientific community. His work is pivotal in the ongoing fight against cancer, showcasing his dedication to improving treatment options.
Collaborations
Fang Cao collaborates with esteemed colleagues, including Shaomeng Wang and Hacer Karatas, who contribute to his research endeavors.
Conclusion
Fang Cao's innovative work and patent in cancer treatment exemplify his commitment to advancing medical science. His contributions are vital in the quest for effective cancer therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile